APA (7th ed.) Citation

CN, S., F, S., JN, G., A, P., UN, V., E, L., . . . M, H. (2020). A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 31(2), 257. https://doi.org/10.1016/j.annonc.2019.10.025

Chicago Style (17th ed.) Citation

CN, Sternberg, et al. "A Randomised Phase II Trial of Three Dosing Regimens of Radium-223 in Patients with Bone Metastatic Castration-resistant Prostate Cancer." Annals of Oncology : Official Journal of the European Society for Medical Oncology 31, no. 2 (2020): 257. https://doi.org/10.1016/j.annonc.2019.10.025.

MLA (9th ed.) Citation

CN, Sternberg, et al. "A Randomised Phase II Trial of Three Dosing Regimens of Radium-223 in Patients with Bone Metastatic Castration-resistant Prostate Cancer." Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 31, no. 2, 2020, p. 257, https://doi.org/10.1016/j.annonc.2019.10.025.